Indeed, activating mutations in NFE2L2 have recently been discovered to commonly co-occur with PIK3CA amplification and mutation in multiple squamous-cell carcinomas including lung, and cooccurrence contributed to greater sensitivity to knockout of either gene in cell lines. Here, NFE2L2 is linked to squamous cell carcinoma.